This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

NanoString Technologies Beheer

Beheer criteriumcontroles 2/4

NanoString Technologies' CEO is Brad Gray, appointed in Jun 2010, has a tenure of 13.5 years. total yearly compensation is $7.60M, comprised of 8.5% salary and 91.5% bonuses, including company stock and options. directly owns 0.7% of the company’s shares, worth MX$4.59M. The average tenure of the management team and the board of directors is 8.7 years and 7.3 years respectively.

Belangrijke informatie

Brad Gray

Algemeen directeur

US$7.6m

Totale compensatie

Percentage CEO-salaris	8.5%
Dienstverband CEO	13.5yrs
Eigendom CEO	0.7%
Management gemiddelde ambtstermijn	8.7yrs
Gemiddelde ambtstermijn bestuur	7.3yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Brad Gray's beloning veranderd ten opzichte van NanoString Technologies's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2023	n/a	n/a	-US$166m
Jun 30 2023	n/a	n/a	-US$166m
Mar 31 2023	n/a	n/a	-US$161m
Dec 31 2022	US$8m	US$645k	-US$160m
Sep 30 2022	n/a	n/a	-US$145m
Jun 30 2022	n/a	n/a	-US$139m
Mar 31 2022	n/a	n/a	-US$127m
Dec 31 2021	US$6m	US$640k	-US$115m
Sep 30 2021	n/a	n/a	-US$109m
Jun 30 2021	n/a	n/a	-US$99m
Mar 31 2021	n/a	n/a	-US$99m
Dec 31 2020	US$5m	US$638k	-US$110m
Sep 30 2020	n/a	n/a	-US$63m
Jun 30 2020	n/a	n/a	-US$65m
Mar 31 2020	n/a	n/a	-US$57m
Dec 31 2019	US$7m	US$569k	-US$41m
Sep 30 2019	n/a	n/a	-US$86m
Jun 30 2019	n/a	n/a	-US$80m
Mar 31 2019	n/a	n/a	-US$80m
Dec 31 2018	US$3m	US$565k	-US$77m
Sep 30 2018	n/a	n/a	-US$65m
Jun 30 2018	n/a	n/a	-US$60m
Mar 31 2018	n/a	n/a	-US$44m
Dec 31 2017	US$2m	US$562k	-US$44m
Sep 30 2017	n/a	n/a	-US$46m
Jun 30 2017	n/a	n/a	-US$45m
Mar 31 2017	n/a	n/a	-US$51m
Dec 31 2016	US$2m	US$533k	-US$47m

Compensatie versus markt: Brad's total compensation ($USD7.60M) is above average for companies of similar size in the MX market ($USD211.86K).

Compensatie versus inkomsten: Brad's compensation has increased whilst the company is unprofitable.

CEO

Brad Gray (46 yo)

13.5yrs

Tenure

US$7,596,268

Compensatie

Mr. R. Bradley Gray, also known as Brad, has been the Chief Executive Officer and President of NanoString Technologies, Inc. since June 29, 2010. Mr. Gray worked at Genzyme Genetics, the diagnostic service...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
R. Gray	CEO, President & Director	13.5yrs	US$7.60m	0.70% MX$ 4.6m
K. Bailey	Chief Financial Officer	5.9yrs	US$2.32m	0.16% MX$ 1.0m
Joseph Beechem	Chief Scientific Officer and Senior VP of Research & Development	11.7yrs	US$2.32m	0.20% MX$ 1.3m
Mark Winham	Senior Vice President of Operations	4.2yrs	geen gegevens	geen gegevens
Douglas Farrell	Vice President of Investor Relations & Corporate Communications	7.3yrs	geen gegevens	geen gegevens
Kathryn Surace-Smith	Senior VP of Human Resources & Legal Affairs and Corporate Secretary	10.8yrs	geen gegevens	geen gegevens
David Ghesquiere	Senior Vice President of Corporate & Business Development	10.1yrs	US$1.24m	geen gegevens
Elizabeth Schneider	Senior Global Marketing Manager	no data	geen gegevens	geen gegevens
Philippa Webster	Senior Principal Scientist	no data	geen gegevens	geen gegevens
Todd Garland	Chief Commercial Officer	less than a year	geen gegevens	geen gegevens
Praveer Sharma	Field Application Scientist	no data	geen gegevens	geen gegevens
Anne van der Valk	Executive	no data	geen gegevens	geen gegevens

8.7yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: NSTG *'s management team is seasoned and experienced (8.7 years average tenure).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
R. Gray	CEO, President & Director	13.5yrs	US$7.60m	0.70% MX$ 4.6m
William Young	Independent Director	13.9yrs	US$276.36k	0.13% MX$ 834.8k
Elisha Finney	Independent Chairman	6.6yrs	US$243.86k	0.045% MX$ 290.9k
Charles Waite	Independent Director	19.4yrs	US$243.86k	0.079% MX$ 517.4k
Janet George	Independent Director	2.8yrs	US$233.86k	0.040% MX$ 261.3k
Kirk Malloy	Independent Director	7.3yrs	US$231.36k	0.050% MX$ 328.9k
Teresa Foy	Independent Director	1.7yrs	US$306.44k	0.013% MX$ 85.1k
Gregory Norden	Independent Director	11.4yrs	US$238.86k	0.099% MX$ 643.1k
Dana Rollison	Independent Director	2.8yrs	US$228.86k	0.040% MX$ 261.3k
Chad Nusbaum	Member of Sequencing Advisory Board	no data	geen gegevens	geen gegevens

7.3yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: NSTG *'s board of directors are considered experienced (7.3 years average tenure).

This company listing is no longer active

NanoString Technologies Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Nanostring Appoints Todd Garland as Chief Commercial Officer

Independent Director recently bought Mex$2.2m worth of stock

CEO, President & Director recently bought Mex$9.8m worth of stock

NanoString Technologies, Inc. Announces Resignation of Robert Hershberg from the Board

Recent updates

NS Wind Down Co. Files Form 15

NS Wind Down Co., Inc. Emerged from Bankruptcy

First Amended Disclosure Statement Approved for NanoString Technologies, Inc.

NanoString Technologies, Inc. announced delayed 10-Q filing

Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.

The Nasdaq Stock Market to Delist the Common Stock of Nanostring Technologies

NanoString Technologies, Inc. announced delayed annual 10-K filing

Patient Square Capital, LP agreed to acquire Substantially all assets of global business operations from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $220 million.

NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from NASDAQ Composite Index

NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from S&P Global BMI Index

Motion for Joint Administration Approved for NanoString Technologies, Inc.

Motion for Joint Administration Filed by NanoString Technologies, Inc.

NanoString Technologies, Inc. Filed for Bankruptcy

Nanostring Launches the CosMx 6,000 Plex RNA Assay and Showcases Whole Transcriptome Imaging Capability

NanoString Technologies, Inc. Releases the First Public Dataset of the Whole Transcriptome Obtained At True Single-Cell Resolution on the CosMx Spatial Molecular Imager

NanoString Technologies Receives Non-Compliance Notice from Nasdaq

10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023

NanoString Technologies, Inc. to Report Q3, 2023 Results on Nov 06, 2023

NanoString Technologies, Inc. Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered

Nanostring Appoints Todd Garland as Chief Commercial Officer

New major risk - Negative shareholders equity

Second quarter 2023 earnings released: US$0.92 loss per share (vs US$0.84 loss in 2Q 2022)

NanoString Technologies, Inc. Reiterates Earnings Guidance for the Full Year 2023

Delaware District Court Permits NanoString Technologies, Inc.'s Counterclaims That 10x Genomics and Harvard Violated the Antitrust Laws

NanoString Technologies, Inc. to Report Q2, 2023 Results on Aug 03, 2023

10X Genomics, Inc. Files New Patent Litigation Against Nanostring Technologies, Inc. and Vizgen, Inc. in the European Unified Patent Court

10X Genomics Wins Permanent Injunction Against Nanostring's CosMX Products

NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023

Independent Director recently bought Mex$2.2m worth of stock

Full year 2022 earnings released: US$3.44 loss per share (vs US$2.54 loss in FY 2021)

NanoString Technologies, Inc. to Report Q4, 2022 Results on Feb 28, 2023

NanoString Technologies, Inc. Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology

NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager

NanoString Technologies, Inc. Provides Product and Service Revenue Guidance for the Fourth Quarter and Full Year 2022

CEO, President & Director recently bought Mex$9.8m worth of stock

NanoString Technologies, Inc Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform

Third quarter 2022 earnings released: US$0.79 loss per share (vs US$0.69 loss in 3Q 2021)

Now 21% undervalued after recent price drop

NanoString Technologies, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Now 30% undervalued

Now 20% undervalued

Now 21% undervalued after recent price drop

Now 20% undervalued

Nanostring Technologies, Inc. Provides Revenue Guidance for 2022

Second quarter 2022 earnings released: US$0.84 loss per share (vs US$0.60 loss in 2Q 2021)

NanoString Technologies, Inc. to Report Q2, 2022 Results on Aug 04, 2022

NanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting

Nanostring Technologies, Inc. Announces Plans to Commercially Unveil the Cosmx™ Spatial Molecular Imager

NanoString Technologies, Inc. Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing

NanoString Technologies, Inc. Announces Resignation of Robert Hershberg from the Board

NanoString Technologies, Inc. Launches New nCounter Pro Analysis System

NanoString Technologies, Inc. Announces Release of a Fully Automated GeoMx RNA Protocol on BOND RX Research Staining Systems

NanoString Technologies, Inc. to Report Q4, 2021 Results on Mar 01, 2022

Nanostring Technologies, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2021

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd